Prospective Study of Long-term Outcome After Non-aneurysmal Subarachnoid Hemorrhage
NCT ID: NCT02334657
Last Updated: 2016-05-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
173 participants
OBSERVATIONAL
2013-11-30
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Level and Prognostic Relevance of New Neuroinflammation Markers in Subarachnoid Haemorrhage
NCT03411746
Ultrasound Perfusion Imaging After Aneurysmal Subarachnoid Hemorrhage
NCT01537263
Poor Grade Aneurysmal Subarachnoid Hemorrhage Study Group
NCT04945603
Long-term Prognosis of Emergency Aneurysmal Subarachnoid Hemorrhage
NCT04785976
The Prospective Cohort Study on the Benefit-risk of Antithrombotic or Anticoagulant Therapy in Patients With Unruptured Intracranial Aneurysms Associated With Ischemic Heart Disease or Ischemic Cerebrovascular Disease
NCT03153878
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
SAH was confirmed on computed tomography (CT) or lumbar puncture. Only patients with a non-traumatic SAH were included. In our hospital algorithm all patients with SAH underwent angiography including 3D digital subtraction angiography (DSA) since 2002 to rule out intracranial sources for SAH. In case of a negative initial angiography, DSA was repeated after 14 days. Additionally, magnetic resonance imaging (MRI) of head/spine was performed to rule out any spinal bleeding sources. In patients with blood distribution exceeding the typical perimesencephalic pattern, a third DSA was performed 3 months after SAH. The first (short-term) follow-up (F/U) was performed six months after ictus. Outcome was measured according to the modified Rankin Scale (mRS) and stratified into favorable (mRS 0-2) and unfavorable (mRS 3-6) after six months. Patients with non-aSAH were divided into perimesencephalic SAH (PM-SAH), non-perimesencephalic SAH (NPM-SAH) and excellent Outcome group (mRS 0). Also the NPM-SAH group was further stratified into Fisher 3 blood pattern and NPM-SAH without Fisher 3 blood pattern.
Patients, at least 18 months after ictus of a non-aneurysmal SAH, received a regular mail including a letter explaining the study purpose and the postal questionnaire consisting a short-form health survey with 36 simple questions. If we didn't receive answers after three months we made telephone interviews with the patients' family members or their general practitioner.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
non-aneurysmal subarachnoid hemorrhage
patients with non-aneurysmal subarachnoid hemorrhage, short-term outcome measured by modified Rankin Scale and long-term outcome by SF-36
SF-36
postal questionnaire consisting a short-form health survey with 36 simple questions (SF-36)
perimesencephalic SAH
subgroup of non-aneurysmal subarachnoid hemorrhage
SF-36
postal questionnaire consisting a short-form health survey with 36 simple questions (SF-36)
non-perimesencephalic (NPM) SAH
subgroup of non-aneurysmal subarachnoid hemorrhage
SF-36
postal questionnaire consisting a short-form health survey with 36 simple questions (SF-36)
subgroup of NPM-SAH with Fisher 3
patients with non-aneurysmal (non-perimesencephalic) SAH and a Fisher 3 bleeding pattern
SF-36
postal questionnaire consisting a short-form health survey with 36 simple questions (SF-36)
subgroup of NPM-SAH w/o Fisher 3
patients with non-aneurysmal (non-perimesencephalic) SAH and not a Fisher 3 bleeding pattern
SF-36
postal questionnaire consisting a short-form health survey with 36 simple questions (SF-36)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SF-36
postal questionnaire consisting a short-form health survey with 36 simple questions (SF-36)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* SAH confirmed on computed tomography (CT) or lumbar puncture
* negative initial and follow-up angiography
* age: no limit
Exclusion Criteria
* aneurysmal SAH
* SAH in whom other bleeding sources were identified (AVM etc.)
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Clinic Frankfurt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Juergen Konczalla
Dr. med.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Juergen Konczalla, MD
Role: PRINCIPAL_INVESTIGATOR
Goethe University Hospital, Department of Neurosurgery
References
Explore related publications, articles, or registry entries linked to this study.
Konczalla J, Schmitz J, Kashefiolasl S, Senft C, Platz J, Seifert V. Non-aneurysmal non-perimesencephalic subarachnoid hemorrhage: effect of rehabilitation at short-term and in a prospective study of long-term follow-up. Top Stroke Rehabil. 2016 Aug;23(4):261-8. doi: 10.1080/10749357.2016.1149982. Epub 2016 Mar 15.
Konczalla J, Schmitz J, Kashefiolasl S, Senft C, Seifert V, Platz J. Non-aneurysmal subarachnoid hemorrhage in 173 patients: a prospective study of long-term outcome. Eur J Neurol. 2015 Oct;22(10):1329-36. doi: 10.1111/ene.12762. Epub 2015 Jul 1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
109/13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.